AXIM Biotechnologies, Inc.

AXIM ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Sep 23, 2022 PRIMARY DOCUMENT
4 Sep 23, 2022 PRIMARY DOCUMENT
4 Sep 23, 2022 PRIMARY DOCUMENT
4 Sep 23, 2022 PRIMARY DOCUMENT
4 Sep 23, 2022 PRIMARY DOCUMENT
4 Sep 23, 2022 PRIMARY DOCUMENT
4 Sep 23, 2022 PRIMARY DOCUMENT
SC 13D Sep 23, 2022 SCHEDULE 13D - JUNIPER & IVY CORP
3 Sep 23, 2022 PRIMARY DOCUMENT
8-K Sep 19, 2022 AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING
SC 13D/A Aug 31, 2022 SCHEDULE 13D/A - CATALINA VALENCIA
4 Aug 31, 2022 PRIMARY DOCUMENT
SC 13D Aug 31, 2022 SCHEDULE 13D - GLYCODOTS, LLC
3 Aug 31, 2022 PRIMARY DOCUMENT
SC 13D Aug 31, 2022 SCHEDULE 13D - CATALINA VALENCIA
3 Aug 31, 2022 PRIMARY DOCUMENT
8-K Aug 29, 2022 AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING
4 Aug 26, 2022 PRIMARY DOCUMENT
10-Q Aug 16, 2022 FORM 10-Q
NT 10-Q Aug 16, 2022 AXIM BIOTECHNOLOGIES, INC. FORM NT 10-Q
EFFECT Aug 4, 2022
CORRESP Aug 2, 2022
S-1/A Aug 2, 2022 AXIM BIOTECHNOLOGIES, INC. - FORM S1A
UPLOAD Jul 29, 2022
S-1 Jul 25, 2022 AXIM BIOTECHNOLOGIES, INC. - FORM S-1
← Newer Page 3 of 13 · 306 filings Older →